Deep-Dive Analysis
Artrya (ASX: AYA) Investment Analysis: Can This AI-Driven Medtech Find Its Commercial Breakthrough?
Artrya has built its story around a simple but powerful problem. Heart disease remains the world’s leading killer, yet the diagnostic toolkit used to detect…
The Investor Standard – Your Investing Edge
Receive curated weekly stock picks, top-performing equities, and actionable investment ideas to maximise your portfolio potential.
Investor Insights, Delivered
Unlock expert insights, stock recommendations, and market analysis – all in one place. Get the latest market news and stock picks instantly.
Further Analysis & Commentary
ASX Caught Between Nvidia Jitters and Rate Reality
The Australia market is stuck in a tug-of-war. Banks and speculative growth names under pressure as investors rethink how many…
Lithium Just Woke Up Again, And the Market Wasn’t Ready for It
A surge in energy-storage demand, a bold Ganfeng forecast and a brutal short squeeze are reshaping the lithium trade Lithium…
RBA Boxed In Recovery: What Hauser’s Stronger-Start Message Means for Markets
The RBA says this easing cycle began from the tightest starting point in at least 45 years, demand already brushing…
AI Funding Reality Check: From Capex Promises to Cash Flows
The AI trade hasn't broken; it's grown up. Markets are now asking the only question that matters for multi-trillion capex…
Socials
Monthly Investor Memo
September 2025